Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F1BKA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,966
Award facts
- Contract value 100% obligated
- $17,965.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,965.90 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit doses) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, competitively awarded delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for RINVOQ ER—a rheumatoid arthritis treatment—exemplifies the routine pharmaceutical fulfillment activity conducted under the company's overarching prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26F1BKA?
SPE2DR26F1BKA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F1BKA worth?
The government has obligated $17,966 on SPE2DR26F1BKA.
Is contract SPE2DR26F1BKA an order under another contract?
Yes. SPE2DR26F1BKA is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BKA competed?
The extent of competition for SPE2DR26F1BKA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award